Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Estradiol cypionate preparation |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Estradiol cypionate |
Inferred relationship |
Some |
|
Estradiol cypionate 5mg/mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Estradiol cypionate |
Inferred relationship |
Some |
|
Estradiol cypionate 5mg/cc |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Estradiol cypionate |
Inferred relationship |
Some |
|
Estradiol cypionate 5mg/cc injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Estradiol cypionate |
Inferred relationship |
Some |
|
Estradiol cypionate + testosterone cypionate 2mg/50mg injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Estradiol cypionate |
Inferred relationship |
Some |
|
Estradiol cypionate + medroxyprogesterone acetate 5mg/25mg injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Estradiol cypionate |
Inferred relationship |
Some |
|
Product containing estradiol cypionate and medroxyprogesterone acetate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Estradiol cypionate |
Inferred relationship |
Some |
|
Product containing estradiol cypionate and medroxyprogesterone acetate in parenteral dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Estradiol cypionate |
Inferred relationship |
Some |
|
Estradiol cypionate 10 mg/mL and medroxyprogesterone acetate 50 mg/mL prolonged-release suspension for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Estradiol cypionate |
Inferred relationship |
Some |
1 |
Estradiol cypionate 10 mg/mL and medroxyprogesterone acetate 50 mg/mL prolonged-release suspension for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Estradiol cypionate |
Inferred relationship |
Some |
1 |